Survival outcomes in older men with non-metastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: a US Food and Drug Administration pooled analysis of patient-level data from three randomised trialsJaleh Fallah, Harpreet Singh, Bellinda L. King‐Kallimanis et al.|The Lancet Oncology|2021Cited by 15
Metastasis free survival in older men with nonmetastatic castration-resistant prostate cancer treated with androgen receptor inhibitors: An FDA-pooled analysis.Harpreet Singh, Julia A. Beaver, Lijun Zhang et al.|Journal of Clinical Oncology|2020Cited by 0